vs

Side-by-side financial comparison of Fastly, Inc. (FSLY) and VERACYTE, INC. (VCYT). Click either name above to swap in a different company.

Fastly, Inc. is the larger business by last-quarter revenue ($172.6M vs $140.6M, roughly 1.2× VERACYTE, INC.). VERACYTE, INC. runs the higher net margin — 29.3% vs -9.0%, a 38.2% gap on every dollar of revenue. On growth, Fastly, Inc. posted the faster year-over-year revenue change (22.8% vs 18.5%). VERACYTE, INC. produced more free cash flow last quarter ($48.8M vs $12.2M). Over the past eight quarters, VERACYTE, INC.'s revenue compounded faster (20.5% CAGR vs 13.7%).

Fastly, Inc. is an American company based in San Francisco, which describes itself as a cloud computing company. Fastly provides content delivery network services, image optimization, and load balancing services. Fastly's cloud security services include denial-of-service attack protection, bot mitigation, and a web application firewall.

Veracyte Inc. is a leading molecular diagnostics company that develops and commercializes proprietary genomic testing solutions for early, accurate detection of cancer and other complex diseases. Its offerings help healthcare providers make better clinical decisions to improve patient outcomes, with core operations in the U.S. and expanding global market presence across key clinical segments.

FSLY vs VCYT — Head-to-Head

Bigger by revenue
FSLY
FSLY
1.2× larger
FSLY
$172.6M
$140.6M
VCYT
Growing faster (revenue YoY)
FSLY
FSLY
+4.2% gap
FSLY
22.8%
18.5%
VCYT
Higher net margin
VCYT
VCYT
38.2% more per $
VCYT
29.3%
-9.0%
FSLY
More free cash flow
VCYT
VCYT
$36.6M more FCF
VCYT
$48.8M
$12.2M
FSLY
Faster 2-yr revenue CAGR
VCYT
VCYT
Annualised
VCYT
20.5%
13.7%
FSLY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FSLY
FSLY
VCYT
VCYT
Revenue
$172.6M
$140.6M
Net Profit
$-15.5M
$41.1M
Gross Margin
61.4%
72.5%
Operating Margin
-8.7%
26.4%
Net Margin
-9.0%
29.3%
Revenue YoY
22.8%
18.5%
Net Profit YoY
52.9%
704.8%
EPS (diluted)
$-0.10
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FSLY
FSLY
VCYT
VCYT
Q4 25
$172.6M
$140.6M
Q3 25
$158.2M
$131.9M
Q2 25
$148.7M
$130.2M
Q1 25
$144.5M
$114.5M
Q4 24
$140.6M
$118.6M
Q3 24
$137.2M
$115.9M
Q2 24
$132.4M
$114.4M
Q1 24
$133.5M
$96.8M
Net Profit
FSLY
FSLY
VCYT
VCYT
Q4 25
$-15.5M
$41.1M
Q3 25
$-29.5M
$19.1M
Q2 25
$-37.5M
$-980.0K
Q1 25
$-39.1M
$7.0M
Q4 24
$-32.9M
$5.1M
Q3 24
$-38.0M
$15.2M
Q2 24
$-43.7M
$5.7M
Q1 24
$-43.4M
$-1.9M
Gross Margin
FSLY
FSLY
VCYT
VCYT
Q4 25
61.4%
72.5%
Q3 25
58.4%
69.2%
Q2 25
54.5%
69.0%
Q1 25
53.2%
69.5%
Q4 24
53.4%
66.4%
Q3 24
54.5%
68.2%
Q2 24
55.1%
68.1%
Q1 24
54.8%
64.5%
Operating Margin
FSLY
FSLY
VCYT
VCYT
Q4 25
-8.7%
26.4%
Q3 25
-18.2%
17.4%
Q2 25
-24.8%
-4.0%
Q1 25
-26.4%
2.5%
Q4 24
-24.4%
3.5%
Q3 24
-29.6%
10.4%
Q2 24
-35.3%
4.0%
Q1 24
-34.6%
-4.8%
Net Margin
FSLY
FSLY
VCYT
VCYT
Q4 25
-9.0%
29.3%
Q3 25
-18.6%
14.5%
Q2 25
-25.2%
-0.8%
Q1 25
-27.1%
6.2%
Q4 24
-23.4%
4.3%
Q3 24
-27.7%
13.1%
Q2 24
-33.0%
5.0%
Q1 24
-32.5%
-1.9%
EPS (diluted)
FSLY
FSLY
VCYT
VCYT
Q4 25
$-0.10
$0.50
Q3 25
$-0.20
$0.24
Q2 25
$-0.26
$-0.01
Q1 25
$-0.27
$0.09
Q4 24
$-0.23
$0.07
Q3 24
$-0.27
$0.19
Q2 24
$-0.32
$0.07
Q1 24
$-0.32
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FSLY
FSLY
VCYT
VCYT
Cash + ST InvestmentsLiquidity on hand
$361.8M
$362.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$929.6M
$1.3B
Total Assets
$1.5B
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FSLY
FSLY
VCYT
VCYT
Q4 25
$361.8M
$362.6M
Q3 25
$342.9M
$315.6M
Q2 25
$321.2M
$219.5M
Q1 25
$307.3M
$186.1M
Q4 24
$295.9M
$239.1M
Q3 24
$308.2M
$274.1M
Q2 24
$311.8M
$235.9M
Q1 24
$329.5M
$209.2M
Stockholders' Equity
FSLY
FSLY
VCYT
VCYT
Q4 25
$929.6M
$1.3B
Q3 25
$937.0M
$1.3B
Q2 25
$942.6M
$1.2B
Q1 25
$957.0M
$1.2B
Q4 24
$965.3M
$1.2B
Q3 24
$969.5M
$1.2B
Q2 24
$981.2M
$1.1B
Q1 24
$991.8M
$1.1B
Total Assets
FSLY
FSLY
VCYT
VCYT
Q4 25
$1.5B
$1.4B
Q3 25
$1.5B
$1.4B
Q2 25
$1.5B
$1.3B
Q1 25
$1.4B
$1.3B
Q4 24
$1.5B
$1.3B
Q3 24
$1.5B
$1.3B
Q2 24
$1.5B
$1.2B
Q1 24
$1.5B
$1.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FSLY
FSLY
VCYT
VCYT
Operating Cash FlowLast quarter
$22.4M
$52.6M
Free Cash FlowOCF − Capex
$12.2M
$48.8M
FCF MarginFCF / Revenue
7.1%
34.7%
Capex IntensityCapex / Revenue
5.9%
2.7%
Cash ConversionOCF / Net Profit
1.28×
TTM Free Cash FlowTrailing 4 quarters
$65.8M
$126.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FSLY
FSLY
VCYT
VCYT
Q4 25
$22.4M
$52.6M
Q3 25
$28.9M
$44.8M
Q2 25
$25.8M
$33.6M
Q1 25
$17.3M
$5.4M
Q4 24
$5.2M
$24.5M
Q3 24
$5.0M
$30.0M
Q2 24
$-4.9M
$29.6M
Q1 24
$11.1M
$-9.0M
Free Cash Flow
FSLY
FSLY
VCYT
VCYT
Q4 25
$12.2M
$48.8M
Q3 25
$22.9M
$42.0M
Q2 25
$15.9M
$32.3M
Q1 25
$14.7M
$3.5M
Q4 24
$251.0K
$20.4M
Q3 24
$3.0M
$27.7M
Q2 24
$-6.7M
$26.8M
Q1 24
$9.5M
$-11.1M
FCF Margin
FSLY
FSLY
VCYT
VCYT
Q4 25
7.1%
34.7%
Q3 25
14.5%
31.8%
Q2 25
10.7%
24.8%
Q1 25
10.2%
3.1%
Q4 24
0.2%
17.2%
Q3 24
2.2%
23.9%
Q2 24
-5.1%
23.4%
Q1 24
7.1%
-11.5%
Capex Intensity
FSLY
FSLY
VCYT
VCYT
Q4 25
5.9%
2.7%
Q3 25
3.8%
2.1%
Q2 25
6.6%
1.0%
Q1 25
1.8%
1.6%
Q4 24
3.5%
3.5%
Q3 24
1.5%
1.9%
Q2 24
1.3%
2.4%
Q1 24
1.2%
2.2%
Cash Conversion
FSLY
FSLY
VCYT
VCYT
Q4 25
1.28×
Q3 25
2.34×
Q2 25
Q1 25
0.76×
Q4 24
4.80×
Q3 24
1.98×
Q2 24
5.16×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FSLY
FSLY

Network Services$130.8M76%
Security$35.4M21%
Other$6.4M4%

VCYT
VCYT

Testing$135.8M97%
Products$3.8M3%
Biopharmaceutical And Other$686.0K0%

Related Comparisons